CD8A and neoplasm: Patients with a high CD8+/ buds index demonstrated more favourable features, such as early T stage (P<0.001), absence of vascular invasion (P=0.009), presence of a pushing/expanding tumour border configuration (P=0.005), presence of peritumoural lymphocytic inflammation at the invasive front (P=0.007) and a marginal association with MSI-H status (P=0.052).